Biotech · Private company · Lexington, KY, US
Naprogenix, Inc
Track this companyFree. Adds Naprogenix, Inc to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards1
- Development of JR-220 (4-Chlorobenzylidenamino-guanidine hydrochloride) as a medication for alcohol dependenceFiscal year 2024 · $99.5KNIH RePORTER 3U44AA026126-05S1 · fetched Nov 12, 2026